Literature DB >> 9352538

Reassessment of FDG uptake in tumor cells: high FDG uptake as a reflection of oxygen-independent glycolysis dominant energy production.

A Waki1, Y Fujibayashi, Y Yonekura, N Sadato, Y Ishii, A Yokoyama.   

Abstract

To determine appropriate use of 2-[18F]-fluoro-2-deoxy-D-glucose (FDG) in the diagnosis of malignant tumors, the mechanism of enhanced FDG uptake in tumor cells was reassessed using in vitro cultured cell lines and 3H-deoxyglucose (DG), in combination with possible parameters of aerobic and anaerobic energy production. The high DG uptake in the tumor cells reflected the dependency of energy production on anaerobic glycolysis, and paradoxically on low levels of aerobic oxidative phosphorylation in mitochondria. We discuss here factors underlying anaerobic glycolysis in tumor cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9352538     DOI: 10.1016/s0969-8051(97)00035-8

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  4 in total

1.  Application of positron emission tomography-computed tomography in the diagnosis of pulmonary ground-glass nodules.

Authors:  Lili Hu; Yuanwei Pan; Zhigang Zhou; Jianbo Gao
Journal:  Exp Ther Med       Date:  2017-09-22       Impact factor: 2.447

2.  Metabolic significance of the pattern, intensity and kinetics of 18F-FDG uptake in malignant pleural mesothelioma.

Authors:  V H Gerbaudo; S Britz-Cunningham; D J Sugarbaker; S T Treves
Journal:  Thorax       Date:  2003-12       Impact factor: 9.139

3.  Evaluation of 2-deoxy-D-glucose as a chemotherapeutic agent: mechanism of cell death.

Authors:  R L Aft; F W Zhang; D Gius
Journal:  Br J Cancer       Date:  2002-09-23       Impact factor: 7.640

4.  Spontaneous Resolution of Idiopathic Panniculitis: Role of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Diagnosis and follow-up.

Authors:  Priyanka Verma; Sumeet Gujral; Ramesh V Asopa
Journal:  Indian J Nucl Med       Date:  2018 Jul-Sep
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.